Description

This issue of Vital Signs, released on April 6, 2010, provides a strategic overview of current trends and issues impacting contract research and manufacturing in the pharma & biotech industry. Additionally, a company spotlight is provided for Vaccinogen, a biotechnology company with more than three decades of research into combating cancer by using the body’s own immune system. Reimbursement and regulatory news from the FDA is also provided for the week of March 15, 2010.